Vice President and Head, Clinical Pharmacology @ (April 2021 - January 2024)
Vice President and Head, Clinical Pharmacology, QSP, and Pharmacometrics @ (November 2016 - March 2021)
Senior Scientist, Clinical Pharmacology @ (October 2012 - October 2016)
Senior Investigator, Clinical PK and PD @ (November 2004 - June 2011)
Mark Stroh Education
Cornell University
PhD (Chemical Engineering)
Harvard Medical School
Postdoctoral Fellow
University of California, Berkeley
BS (Chemical Engineering)
Mark Stroh Skills
Clinical Pharmacology
Mathematical Modeling
Pharmacokinetics
Pharmacodynamics
Clinical Development
Drug Development
Drug Discovery
Pharmaceutical Industry
Pharmacology
Drug Metabolism
Biomarkers
Lifesciences
ADME
DMPK
Monoclonal Antibodies
Life Sciences
IND
Assay Development
Biotechnology
Presentation Skills
Team Building
Scientific Leadership
Clinical Trials
Pharmacometrics
Strategic Partnerships
Small Molecules
Interdisciplinary Collaboration
Translational Medicine
Executive Presentation Skills
Phase Ii
Communication
Vendor Management
Team Leadership
Development Strategy
Cancer Immunotherapy
Global Drug Development
Oncology
Cross Functional Team Leadership
Biologics
Regulatory Compliance
Regulatory Submissions
Analytical Skills
Cross Disciplinary Leadership
Project Management
Immunotherapy
Problem Solving
Quantitative Clinical Pharmacology
New Drug Application Nda
New Drug Application
Mark Stroh Summary
Mark Stroh, based in United States, is currently a Senior Vice President, Pharmacology at Metsera. Mark Stroh brings experience from previous roles at Intellia Therapeutics, Inc., CytomX Therapeutics, Genentech and Merck. Mark Stroh holds a PhD in Chemical Engineering @ Cornell University. With a robust skill set that includes Clinical Pharmacology, Mathematical Modeling, Pharmacokinetics, Pharmacodynamics, Clinical Development and more. Mark Stroh has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Mark Stroh?
Find contact details for 700 million professionals.